Katherine A.D. Krueger
Kate is a Senior Associate at VHPM. For more than seven years, she has specialized in helping clients in the biological and biochemical arts fields, evaluating, developing and managing global patent portfolios, as well as performing opinion work. Kate assists clients with inventions related to molecular biology, cellular biology, immunology, gene therapy, RNA inhibition, polymer materials, nanoparticles and diagnostics. When she’s not at work, Kate and her husband are busy raising two daughters. When she does get a moment to herself, Kate enjoys reading.
Kate’s Most Recent Book: All the Light We Cannot See
University of Minnesota Law School, J.D., cum laude, 2009
University of Minnesota, Ph.D., Molecular, Cellular, Developmental Biology & Genetics, 2008
Saint Olaf College, B.A., cum laude, double major in Biology and Economics, 2000
Registered to Practice Before the United States Patent and Trademark Office
American Intellectual Property Law Association
Association of University Technology Managers
“After the Deal Is Done”, AUTM Central Regional Meeting (July 2016) and Eastern Regional Meeting (September 2016).
Jeremy McKown and Katherine Krueger, “Compulsory Licensing and the Impact of Bayer Corporation v. Union of India”, AIPLA Spring Meeting paper (May 2014).
“Association for Molecular Pathology v. Myriad Genetics, Inc.: Isolated DNA is Not Patent Eligible Subject Matter”, LES Minnesota Chapter Meeting, Minneapolis, MN (September 2013).